Forsta AP Fonden lessened its stake in shares of CVS Health Corp (NYSE:CVS) by 33.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 200,000 shares of the pharmacy operator’s stock after selling 100,352 shares during the quarter. Forsta AP Fonden’s holdings in CVS Health were worth $16,264,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also modified their holdings of CVS. Fieldpoint Private Securities LLC lifted its position in CVS Health by 333.3% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares in the last quarter. Arcadia Investment Management Corp MI increased its holdings in CVS Health by 119.6% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 726 shares during the last quarter. MPS Loria Financial Planners LLC purchased a new stake in CVS Health during the 2nd quarter worth approximately $119,000. Gemmer Asset Management LLC increased its holdings in CVS Health by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 200 shares during the last quarter. Finally, Captrust Financial Advisors purchased a new stake in CVS Health during the 2nd quarter worth approximately $155,000. 81.70% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts have issued reports on the company. Mizuho set a $95.00 price objective on CVS Health and gave the stock a “buy” rating in a report on Wednesday. Cowen restated an “outperform” rating and set a $99.00 price objective (up from $81.00) on shares of CVS Health in a report on Thursday, January 18th. Vetr downgraded CVS Health from a “hold” rating to a “sell” rating and set a $76.66 price target for the company. in a report on Tuesday, January 16th. Leerink Swann boosted their price target on CVS Health from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Monday, January 8th. Finally, Oppenheimer reiterated a “buy” rating and issued a $95.00 price target on shares of CVS Health in a report on Monday, October 9th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $87.49.
Shares of CVS Health Corp (NYSE CVS) traded up $0.43 during mid-day trading on Friday, reaching $82.01. The company’s stock had a trading volume of 5,773,056 shares, compared to its average volume of 8,270,000. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. CVS Health Corp has a one year low of $66.45 and a one year high of $84.00. The firm has a market cap of $83,080.00, a price-to-earnings ratio of 16.94, a PEG ratio of 1.28 and a beta of 0.90.
CVS Health (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company’s revenue was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.64 earnings per share. analysts predict that CVS Health Corp will post 5.88 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.44%. CVS Health’s dividend payout ratio (DPR) is 41.32%.
In other news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the sale, the executive vice president now owns 15,556 shares in the company, valued at $1,166,700. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.61% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/29/forsta-ap-fonden-lowers-position-in-cvs-health-corp-cvs.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.